Piper Sandler initiates LCNB stock at Neutral, sets $20 target

LCNB CORP (LCNB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 ex_969417.htm EXHIBIT 99.2 ex_969417.htm Exhibit 99.2 LCNB Corp. and Subsidiaries Financial Highlights (Dollars in thousands, except per share amounts) (Unaudited) Three Months Ended Six Months Ended 6/30/2026 3/31/2026 12/31/2025 9/30/2025 6/30/2025 6/30/2026 6/30/2025

Stifel kept its Hold rating and $100 price target on Lululemon (LULU) after leadership changes. The stock trades near its 52-week low, down 56% YTD. Lululemon reported a 4.3% Q2 revenue decline to $2.42B. Analysts cite weak demand and increased promotions. LULU's board expanded to 12 members with new CEO Heidi O'Neill.

NVIDIA is investing in both proprietary and open-source AI models, including a $90M Series B round for Nous Research, valuing it at $1.5B. Nous claims its Hermes 4.3 model outperforms GPT-4o in key metrics, but lacks independent verification. The company aims to compete with lower pricing, offering $0.30 per million tokens compared to competitors' higher rates. NVIDIA's strategy ensures its hardware remains central to AI infrastructure regardless of the winning model architecture.

Quantum computing stocks like IONQ, QBTS, RGTI, and QUBT fell sharply on Wednesday due to rising U.S. Treasury yields, which increased borrowing costs and affected valuations of speculative tech companies. The 10-year Treasury yield briefly hit 5.36%, its highest since 2002. IonQ announced a $300 million DARPA agreement after market close, unrelated to the day's decline.

Biohaven (BHVN) has licensed its IgG degrader portfolio to Ono Pharma for Asian markets, including Japan and South Korea. The deal includes up to $100M in payments, with Biohaven retaining rights outside these regions. The portfolio, led by BHV-1300 in Phase 3 trials for Graves' disease, aims to treat autoimmune disorders. Biohaven's stock closed at $11.88, up 1.18% in pre-market trading.

NASA plans to invest $359 million more in Boeing's Starliner capsule for ISS missions, despite technical issues. The agency aims to send an unmanned Starliner to the ISS by late 2027, with a manned mission possible in 2028. The ISS is set to retire by 2030. SpaceX's Dragon Crew is noted as a cheaper, more reliable alternative. NASA insists on having two providers for ISS missions. Dr. Ken Kremer, a space expert, highlights the high stakes of maintaining a presence in low Earth orbit.